In the in vitro part of our study, LCD exerts pharmacological effects, revealing its potential as a COX2 inhibitor and the molecular mechanism by which LCD prevents ICH-mediated ferroptosis, suppresses oxidative stress, and alleviates inflammatory responses. The gene discussed is PTGER2; the disease is lattice corneal dystrophy type I.